[144] Zepp Health Corporation American depositary shares, each representing sixteen Class A ordinary shares SEC Filing

Rhea-AI Filing Summary

Zepp Health Corporation (ZEPP) filing a Form 144 notifies a proposed sale of 1,745 ADRs representing American depositary shares, with an aggregate market value of $60,656.20. The ADRs trade on the NYSE and the filing lists an approximate sale date of 08/27/2025. The securities were acquired through the vesting of restricted share units from Zepp Health between March 2018 and February 2020, and no sales by the holder in the past three months were reported.

Insights

Securities Compliance Analyst

TL;DR: Routine Form 144 disclosure of a small proposed ADR sale stemming from vested RSUs; mainly a compliance notice.

The filing documents a proposed sale of 1,745 ADRs with an aggregate market value of $60,656.20 on NYSE, scheduled approximately 08/27/2025. All reported acquisitions are described as vesting of restricted share units between 2018 and 2020. No securities sales in the past three months are listed. From a compliance perspective, this aligns with Rule 144 notice requirements and signals the holder is notifying the market of intent to sell vested shares rather than a corporate event.

Equity Markets Analyst

TL;DR: Small-scale insider/affiliate sale notice; unlikely to be market-impactful given size relative to outstanding shares.

The proposed sale quantity (1,745 ADRs) represents a negligible fraction of the reported 7,040,000 ADRs outstanding, implying limited potential impact on supply or market price. The acquisitions were all via RSU vesting, indicating these are previously earned compensatory awards rather than new issuances. The absence of recent sales by the holder and the routine nature of the disclosure suggest this is a standard liquidity event by an insider or former insider.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
ADR(Common)	The Core Securities Co., Ltd. Standard Chartered Bank 4-4A Des Voeux Road Central Central K3 999077	1745	60656.20	7040000	08/27/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
ADR(Common)	03/08/2018	Vesting of Restricted Share Units	Zepp Health Corporation			81	03/08/2018	Vesting of Restricted Share Units
ADR(Common)	04/08/2018	Vesting of Restricted Share Units	Zepp Health Corporation			82	04/08/2018	Vesting of Restricted Share Units
ADR(Common)	05/08/2018	Vesting of Restricted Share Units	Zepp Health Corporation			82	05/08/2018	Vesting of Restricted Share Units
ADR(Common)	06/08/2018	Vesting of Restricted Share Units	Zepp Health Corporation			82	06/08/2018	Vesting of Restricted Share Units
ADR(Common)	07/08/2018	Vesting of Restricted Share Units	Zepp Health Corporation			81	07/08/2018	Vesting of Restricted Share Units
ADR(Common)	03/08/2019	Vesting of Restricted Share Units	Zepp Health Corporation			63	03/08/2019	Vesting of Restricted Share Units
ADR(Common)	04/08/2019	Vesting of Restricted Share Units	Zepp Health Corporation			64	04/08/2019	Vesting of Restricted Share Units
ADR(Common)	05/08/2019	Vesting of Restricted Share Units	Zepp Health Corporation			64	05/08/2019	Vesting of Restricted Share Units
ADR(Common)	06/08/2019	Vesting of Restricted Share Units	Zepp Health Corporation			64	06/08/2019	Vesting of Restricted Share Units
ADR(Common)	07/08/2019	Vesting of Restricted Share Units	Zepp Health Corporation			63	07/08/2019	Vesting of Restricted Share Units
ADR(Common)	07/11/2019	Vesting of Restricted Share Units	Zepp Health Corporation			572	07/11/2019	Vesting of Restricted Share Units
ADR(Common)	08/08/2019	Vesting of Restricted Share Units	Zepp Health Corporation			64	08/08/2019	Vesting of Restricted Share Units
ADR(Common)	09/08/2019	Vesting of Restricted Share Units	Zepp Health Corporation			64	09/08/2019	Vesting of Restricted Share Units
ADR(Common)	10/08/2019	Vesting of Restricted Share Units	Zepp Health Corporation			64	10/08/2019	Vesting of Restricted Share Units
ADR(Common)	11/08/2019	Vesting of Restricted Share Units	Zepp Health Corporation			63	11/08/2019	Vesting of Restricted Share Units
ADR(Common)	12/08/2019	Vesting of Restricted Share Units	Zepp Health Corporation			64	12/08/2019	Vesting of Restricted Share Units
ADR(Common)	01/08/2020	Vesting of Restricted Share Units	Zepp Health Corporation			64	01/08/2020	Vesting of Restricted Share Units
ADR(Common)	02/08/2020	Vesting of Restricted Share Units	Zepp Health Corporation			64	02/08/2020	Vesting of Restricted Share Units

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for ZEPP disclose?

The Form 144 notifies a proposed sale of 1,745 ADRs with an aggregate market value of $60,656.20, to occur approximately on 08/27/2025 on the NYSE.

How were the securities being sold acquired according to the filing?

The filing states the ADRs were acquired through the vesting of restricted share units from Zepp Health Corporation on multiple dates between March 2018 and February 2020.

Does the filing report any sales by the holder in the past three months?

No. The filing explicitly states "Nothing to Report" for securities sold during the past three months by the person for whose account the securities are to be sold.

On which exchange will the proposed sale take place?

The filing lists the New York Stock Exchange (NYSE) as the securities exchange for the proposed sale.

How many ADRs are outstanding according to the Form 144?

The filing reports 7,040,000 ADRs outstanding.